कृपया अन्य खोज का प्रयास करें
BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
John P. McDonough | 63 | 2021 | Independent Chairman of the Board |
Jean-Louis Vincent | - | 2014 | Chairman of the Scientific Advisory Board |
Donnie M. Hardison | 74 | 2021 | Independent Vice Chairman of the Board |
Peter Morch Eriksen | 64 | 2021 | CEO & Director |
Claudio Ronco | - | 2014 | Member of Scientific Advisory Board |
Laurent Jacob | - | 2014 | Member of Scientific Advisory Board |
Andrew Lewington | - | 2014 | Vice Chairman of Scientific Advisory Board |
Michael Haase | - | 2014 | Member of Scientific Advisory Board |
Michael Scott Singer | 51 | 2019 | Independent Director |
Hilde Rh De Geus | - | 2014 | Member of Scientific Advisory Board |
Ninfa M. Saunders | 65 | 2023 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है